eCARTv5的多中心开发和前瞻性验证:梯度增强的机器学习预警评分。

Q4 Medicine
Critical care explorations Pub Date : 2025-03-26 eCollection Date: 2025-04-01 DOI:10.1097/CCE.0000000000001232
Matthew M Churpek, Kyle A Carey, Ashley Snyder, Christopher J Winslow, Emily Gilbert, Nirav S Shah, Brian W Patterson, Majid Afshar, Alan Weiss, Devendra N Amin, Deborah J Rhodes, Dana P Edelson
{"title":"eCARTv5的多中心开发和前瞻性验证:梯度增强的机器学习预警评分。","authors":"Matthew M Churpek, Kyle A Carey, Ashley Snyder, Christopher J Winslow, Emily Gilbert, Nirav S Shah, Brian W Patterson, Majid Afshar, Alan Weiss, Devendra N Amin, Deborah J Rhodes, Dana P Edelson","doi":"10.1097/CCE.0000000000001232","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Early detection of clinical deterioration using machine-learning early warning scores may improve outcomes. However, most implemented scores were developed using logistic regression, only underwent retrospective validation, and were not tested in important subgroups.</p><p><strong>Objective: </strong>The objective of our multicenter retrospective and prospective observational study was to develop and prospectively validate a gradient-boosted machine model (eCARTv5) for identifying clinical deterioration on the wards.</p><p><strong>Derivation cohort: </strong>All adult patients admitted to the inpatient medical-surgical wards at seven hospitals in three health systems for model development (2006-2022).</p><p><strong>Validation cohort: </strong>All adult patients admitted to the inpatient medical-surgical wards and at 21 hospitals from three health systems for retrospective (2009-2023) and prospective (2023-2024) external validation.</p><p><strong>Prediction model: </strong>Predictor variables (demographics, vital signs, documentation, and laboratory values) were used in a gradient-boosted trees algorithm to predict ICU transfer or death in the next 24 hours. The developed model (eCARTv5) was compared with the Modified Early Warning Score (MEWS), the National Early Warning Score (NEWS), and eCARTv2 using the area under the receiver operating characteristic curve (AUROC).</p><p><strong>Results: </strong>The development cohort included 901,491 admissions, the retrospective validation cohort included 1,769,461 admissions, and the prospective validation cohort included 205,946 admissions. In retrospective validation, eCARTv5 had the highest AUROC (0.834; 95% CI, 0.834-0.835), followed by eCARTv2 (0.775 [95% CI, 0.775-0.776]), NEWS (0.766 [95% CI, 0.766-0.767]), and MEWS (0.704 [95% CI, 0.703-0.704]). eCARTv5's performance remained high (AUROC ≥0.80) across a range of patient demographics, clinical conditions, and during prospective validation.</p><p><strong>Conclusion: </strong>We developed eCARTv5, which performed better than eCARTv2, NEWS, and MEWS retrospectively, prospectively, and across a range of subgroups. These results served as the foundation for Food and Drug Administration clearance for its use in identifying deterioration in hospitalized ward patients.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"7 4","pages":"e1232"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11949291/pdf/","citationCount":"0","resultStr":"{\"title\":\"Multicenter Development and Prospective Validation of eCARTv5: A Gradient-Boosted Machine-Learning Early Warning Score.\",\"authors\":\"Matthew M Churpek, Kyle A Carey, Ashley Snyder, Christopher J Winslow, Emily Gilbert, Nirav S Shah, Brian W Patterson, Majid Afshar, Alan Weiss, Devendra N Amin, Deborah J Rhodes, Dana P Edelson\",\"doi\":\"10.1097/CCE.0000000000001232\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Early detection of clinical deterioration using machine-learning early warning scores may improve outcomes. However, most implemented scores were developed using logistic regression, only underwent retrospective validation, and were not tested in important subgroups.</p><p><strong>Objective: </strong>The objective of our multicenter retrospective and prospective observational study was to develop and prospectively validate a gradient-boosted machine model (eCARTv5) for identifying clinical deterioration on the wards.</p><p><strong>Derivation cohort: </strong>All adult patients admitted to the inpatient medical-surgical wards at seven hospitals in three health systems for model development (2006-2022).</p><p><strong>Validation cohort: </strong>All adult patients admitted to the inpatient medical-surgical wards and at 21 hospitals from three health systems for retrospective (2009-2023) and prospective (2023-2024) external validation.</p><p><strong>Prediction model: </strong>Predictor variables (demographics, vital signs, documentation, and laboratory values) were used in a gradient-boosted trees algorithm to predict ICU transfer or death in the next 24 hours. The developed model (eCARTv5) was compared with the Modified Early Warning Score (MEWS), the National Early Warning Score (NEWS), and eCARTv2 using the area under the receiver operating characteristic curve (AUROC).</p><p><strong>Results: </strong>The development cohort included 901,491 admissions, the retrospective validation cohort included 1,769,461 admissions, and the prospective validation cohort included 205,946 admissions. In retrospective validation, eCARTv5 had the highest AUROC (0.834; 95% CI, 0.834-0.835), followed by eCARTv2 (0.775 [95% CI, 0.775-0.776]), NEWS (0.766 [95% CI, 0.766-0.767]), and MEWS (0.704 [95% CI, 0.703-0.704]). eCARTv5's performance remained high (AUROC ≥0.80) across a range of patient demographics, clinical conditions, and during prospective validation.</p><p><strong>Conclusion: </strong>We developed eCARTv5, which performed better than eCARTv2, NEWS, and MEWS retrospectively, prospectively, and across a range of subgroups. These results served as the foundation for Food and Drug Administration clearance for its use in identifying deterioration in hospitalized ward patients.</p>\",\"PeriodicalId\":93957,\"journal\":{\"name\":\"Critical care explorations\",\"volume\":\"7 4\",\"pages\":\"e1232\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11949291/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical care explorations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/CCE.0000000000001232\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical care explorations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CCE.0000000000001232","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景:使用机器学习早期预警评分早期发现临床恶化可能会改善预后。然而,大多数实施的评分是使用逻辑回归开发的,只进行了回顾性验证,并且没有在重要的亚组中进行测试。目的:我们的多中心回顾性和前瞻性观察性研究的目的是开发并前瞻性验证用于识别病房临床恶化的梯度增强机器模型(eCARTv5)。衍生队列:为模型开发(2006-2022),在三个卫生系统的七家医院的住院内科-外科病房收治的所有成年患者。验证队列:回顾性(2009-2023)和前瞻性(2023-2024)外部验证来自三个卫生系统的21家医院住院内科-外科病房的所有成年患者。预测模型:在梯度增强树算法中使用预测变量(人口统计学、生命体征、文献和实验室值)来预测未来24小时的ICU转移或死亡。利用受试者工作特征曲线下面积(AUROC)将所建立的模型(eCARTv5)与修正预警评分(MEWS)、国家预警评分(NEWS)和eCARTv2进行比较。结果:发展队列包括901,491名入院者,回顾性验证队列包括1,769,461名入院者,前瞻性验证队列包括205,946名入院者。回顾性验证中,eCARTv5的AUROC最高(0.834;95% CI, 0.834-0.835),其次是eCARTv2 (0.775 [95% CI, 0.775-0.776])、NEWS (0.766 [95% CI, 0.766-0.767])和MEWS (0.704 [95% CI, 0.703-0.704])。eCARTv5在一系列患者人口统计学、临床条件和前瞻性验证期间的表现仍然很高(AUROC≥0.80)。结论:我们开发的eCARTv5在回顾性、前瞻性和一系列亚组中表现优于eCARTv2、NEWS和MEWS。这些结果为食品和药物管理局批准其用于识别住院病房患者的恶化奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Multicenter Development and Prospective Validation of eCARTv5: A Gradient-Boosted Machine-Learning Early Warning Score.

Background: Early detection of clinical deterioration using machine-learning early warning scores may improve outcomes. However, most implemented scores were developed using logistic regression, only underwent retrospective validation, and were not tested in important subgroups.

Objective: The objective of our multicenter retrospective and prospective observational study was to develop and prospectively validate a gradient-boosted machine model (eCARTv5) for identifying clinical deterioration on the wards.

Derivation cohort: All adult patients admitted to the inpatient medical-surgical wards at seven hospitals in three health systems for model development (2006-2022).

Validation cohort: All adult patients admitted to the inpatient medical-surgical wards and at 21 hospitals from three health systems for retrospective (2009-2023) and prospective (2023-2024) external validation.

Prediction model: Predictor variables (demographics, vital signs, documentation, and laboratory values) were used in a gradient-boosted trees algorithm to predict ICU transfer or death in the next 24 hours. The developed model (eCARTv5) was compared with the Modified Early Warning Score (MEWS), the National Early Warning Score (NEWS), and eCARTv2 using the area under the receiver operating characteristic curve (AUROC).

Results: The development cohort included 901,491 admissions, the retrospective validation cohort included 1,769,461 admissions, and the prospective validation cohort included 205,946 admissions. In retrospective validation, eCARTv5 had the highest AUROC (0.834; 95% CI, 0.834-0.835), followed by eCARTv2 (0.775 [95% CI, 0.775-0.776]), NEWS (0.766 [95% CI, 0.766-0.767]), and MEWS (0.704 [95% CI, 0.703-0.704]). eCARTv5's performance remained high (AUROC ≥0.80) across a range of patient demographics, clinical conditions, and during prospective validation.

Conclusion: We developed eCARTv5, which performed better than eCARTv2, NEWS, and MEWS retrospectively, prospectively, and across a range of subgroups. These results served as the foundation for Food and Drug Administration clearance for its use in identifying deterioration in hospitalized ward patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.70
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信